The Role of IntraNasal Insulin in Regulating HepaTic Lipid COntent in HUMANS
Clinical trial NCT02164032 · UNKNOWN
Trial details
- NCT number
- NCT02164032
- Sponsor
- Medical University of Vienna
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.